V. Mollaki

发表

Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers

Vasiliki Mavroidopoulou, Ellie Xera, V. Mollaki, 2015, Journal of Human Genetics.

Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.

S. Humphries, M. Bourbon, H. Esterbauer, 2021, Atherosclerosis.

Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum.

P. Progias, V. Mollaki, E. Drogari, 2014, Atherosclerosis.

Genetic causes of monogenic familial hypercholesterolemia in the Greek population: Lessons, mistakes, and the way forward.

V. Mollaki, E. Drogari, 2016, Journal of clinical lipidology.

Genetic analysis and clinical description of Greek patients with Peutz-Jeghers syndrome: Creation of a National Registry.

F. Fostira, D. Yannoukakos, G. Alexandrakis, 2018, Cancer genetics.

Ethical Challenges in Organoid Use

V. Mollaki, 2021, Biotech (Basel (Switzerland)).

Novel LDLR Variants in Patients with Familial Hypercholesterolemia: In Silico Analysis as a Tool to Predict Pathogenic Variants in Children and Their Families

P. Progias, V. Mollaki, E. Drogari, 2013, Annals of human genetics.

Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.

Sonia Shah, S. Humphries, P. Talmud, 2015, Clinical chemistry.

Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients

F. Fostira, D. Yannoukakos, G. Fountzilas, 2018, Journal of Human Genetics.

Public and physician's expectations and ethical concerns about electronic health record: Benefits outweigh risks except for information security

Eleni Entzeridou, Evgenia Markopoulou, Vasiliki Mollaki, 2018, Int. J. Medical Informatics.

POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.

R. V. van Schaik, V. Manolopoulos, G. Ragia, 2014, Pharmacogenomics.

Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients

F. Fostira, D. Yannoukakos, G. Fountzilas, 2018, Journal of Human Genetics.

Pathology of BRCA1- and BRCA2-associated breast cancers: known and less known connections

F. Fostira, D. Yannoukakos, C. Papadimitriou, 2016 .